Table 2.
Treatment groups | AChE (nmol/min·mg protein) | MDA (ng/mg protein) | SOD (units/mg protein) | CAT (units/mg protein) | GSH-Px (units/mg protein) |
---|---|---|---|---|---|
ND+vehicle | 0.18 ± 0.01 | 0.50 ± 0.07 | 16.29 ± 0.84 | 69.63 ± 9.55 | 8.85 ± 0.54 |
HCHF+sham+vehicle | 0.20 ± 0.01 | 0.55 ± 0.04 | 15.45 ± 0.24 | 66.49 ± 10.23 | 8.41 ± 0.38 |
HCHF+MCAO+vehicle | 0.35 ± 0.01aaa,bbb | 3.06 ± 0.28aaa,bbb | 7.31 ± 0.46aaa,bbb | 46.69 ± 1.10aaa,bbb | 3.96 ± 0.20aaa,bbb |
HCHF+MCAO+vitamin C | 0.31 ± 0.01 | 1.08 ± 0.12∗∗∗ | 9.28 ± 1.12∗∗ | 51.86 ± 6.13∗ | 4.77 ± 0.93∗ |
HCHF+MCAO+donepezil | 0.20 ± 0.03∗∗∗ | 2.82 ± 0.09 | 7.36 ± 1.01 | 47.46 ± 2.77 | 4.27 ± 0.27 |
HCHF+MCAO+PMG50 | 0.25 ± 0.01∗∗ | 0.63 ± 0.07∗∗∗ | 12.41 ± 0.95∗∗∗ | 48.54 ± 13.95 | 6.42 ± 0.57∗∗∗ |
HCHF+MCAO+PMG100 | 0.23 ± 0.01∗∗∗ | 0.63 ± 0.08∗∗∗ | 11.32 ± 1.50∗∗∗ | 60.52 ± 9.76∗∗ | 7.29 ± 1.13∗∗∗ |
HCHF+MCAO+PMG200 | 0.20 ± 0.01∗∗∗ | 0.54 ± 0.04∗∗∗ | 14.17 ± 1.64∗∗∗ | 62.86 ± 5.76∗∗ | 6.76 ± 0.46∗∗∗ |
Data are presented as mean ± SEM (n = 6/group). aaap value < 0.001; compared between control rats which received a normal diet and vehicle and MetS+MCAO rats which received HCHF, MCAO, and vehicle. bbbp value < 0.001; compared between sham rats which received HCHF, sham operation, and vehicle and MetS+MCAO rats which received HCHF, MCAO, and vehicle. ∗p value < 0.05, ∗∗p value < 0.01, and ∗∗∗p value < 0.001; compared to MetS+MCAO rats which received HCHF, MCAO, and vehicle. ND: normal diet; HCHF: high-carbohydrate high-fat diet; MetS: metabolic syndrome; MCAO: middle cerebral artery occlusion; Vitamin C: vitamin C at a dose of 250 mg·kg−1 BW; Donepezil: donepezil at a dose of 3 mg·kg−1 BW; PMG50, PMG100, and PMG200: the phytosomes containing the combined extract of mulberry fruit and ginger at doses of 50, 100, and 200 mg·kg−1 BW, respectively.